ES2195397T3 - Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos. - Google Patents

Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos.

Info

Publication number
ES2195397T3
ES2195397T3 ES98948473T ES98948473T ES2195397T3 ES 2195397 T3 ES2195397 T3 ES 2195397T3 ES 98948473 T ES98948473 T ES 98948473T ES 98948473 T ES98948473 T ES 98948473T ES 2195397 T3 ES2195397 T3 ES 2195397T3
Authority
ES
Spain
Prior art keywords
useful
quinazolin
antibacterial agents
dionas
replaced
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES98948473T
Other languages
English (en)
Inventor
John Michael Domagala
Edmund Lee Ellsworth
Liren Huang
Thomas Eric Renau
Rajeshwar Singh
Michael Andrew Stier
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Warner Lambert Co LLC
Original Assignee
Warner Lambert Co LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co LLC filed Critical Warner Lambert Co LLC
Application granted granted Critical
Publication of ES2195397T3 publication Critical patent/ES2195397T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72Quinazolines; Hydrogenated quinazolines
    • C07D239/95Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in positions 2 and 4
    • C07D239/96Two oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/06Peri-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Furan Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Un compuesto de Fórmula I **fórmula** o una de sus sales farmacéuticamente aceptable, en la que: R1 es H, un alquilo lineal o ramificado de 1 a 6 átomos de carbono, cicloalquilo de 3 a 6 átomos de carbono, un heterociclo de 4 a 6 átomos que posee 1 a 2 heteroátomos seleccionado entre 2- ó 3-tienilo, 2- ó 3- furanilo, 2- ó 3-pirrolilo, 2-, 4-, ó 5-imidazolilo, 3-, 4- ó 5-pirazolilo, 2- 4- ó 5-tiazolilo, 3-, 4- ó 5- isotiazolilo, 2-, 4- ó 5-oxazolilo, 3-, 4- ó 5-isoxazolilo, 2-, 3- ó 4-piridinilo, 3-, 4- ó 5-piridazinilo, 2- pirazinilo, 2-, 4- ó 5-pirimidinilo, 1- ó 2-piperazinilo, 2- , 3- ó 4-morfolinilo, 2-, 3- ó 4-tiomorfolinilo, 1-, 2- ó 3- pirrolidinilo, 2- ó 3-tetrahidrofuranilo, 2-, 3- ó 4- tetrahidropiranilo, 2-, 3- ó 4-piperidinilo, 1-, 2-, 4-, 5- ó 6-tetrahidropirimidinilo, 2-dioxolinilo, 2-, 4- ó 5- imidazolidinilo, incluyendo los heterociclos anteriores que contienen azufre oxidado a grupos SO ó SO2.
ES98948473T 1997-10-28 1998-09-23 Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos. Expired - Lifetime ES2195397T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US6355697P 1997-10-28 1997-10-28
US9858898P 1998-08-31 1998-08-31

Publications (1)

Publication Number Publication Date
ES2195397T3 true ES2195397T3 (es) 2003-12-01

Family

ID=26743531

Family Applications (1)

Application Number Title Priority Date Filing Date
ES98948473T Expired - Lifetime ES2195397T3 (es) 1997-10-28 1998-09-23 Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos.

Country Status (11)

Country Link
US (2) US6331538B1 (es)
EP (1) EP1028950B1 (es)
AT (1) ATE239000T1 (es)
AU (1) AU9503998A (es)
DE (1) DE69814135T2 (es)
DK (1) DK1028950T3 (es)
ES (1) ES2195397T3 (es)
PT (1) PT1028950E (es)
SI (1) SI1028950T1 (es)
WO (1) WO1999021840A1 (es)
ZA (1) ZA989783B (es)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2000041505A2 (en) * 1999-01-13 2000-07-20 Warner-Lambert Company Anthranilic acid derivatives
OA12316A (en) 2000-01-24 2006-05-15 Warner Lambert Co 3-Aminoquinazolin-2,4-dione antibacterial agents.
US7105682B2 (en) * 2001-01-12 2006-09-12 Amgen Inc. Substituted amine derivatives and methods of use
ATE315038T1 (de) 2001-05-30 2006-02-15 Warner Lambert Co Antibakterielle mittel
AU2002302894A1 (en) * 2001-06-19 2003-01-02 Warner-Lambert Company Llc Quinazolinediones as antibacterial agents
DOP2003000556A (es) 2002-01-23 2003-10-31 Warner Lambert Co Esteres hidroxamato de acido n-(4-fenil-sustituido)-antranilico.
JP2005515253A (ja) 2002-01-23 2005-05-26 ワーナー−ランバート・カンパニー、リミテッド、ライアビリティ、カンパニー N−(4−置換フェニル)−アントラニル酸ヒドロキサメートエステル
CA2538420A1 (en) * 2003-09-12 2005-03-24 Warner-Lambert Company Llc Quinolone antibacterial agents
US20050124562A1 (en) * 2003-09-23 2005-06-09 Joseph Guiles Bis-quinazoline compounds for the treatment of bacterial infections
AU2005205016B2 (en) 2004-01-16 2010-07-15 F. Hoffmann-La Roche Ag 1-benzyl-5-piperazin-1-yl-3,4 dihydro-1H-quinazolin-2-one derivatives and the respective 1H-benzo(1,2,6)thiadiazine-2,2-dioxide and 1,4-dihydro-benzo(D) (1,3)oxazin-2-one derivatives as modulators of the 5-hydroxytryptamine receptor (5-HT) for the treatment of diseases of the central nervous system
WO2006019965A2 (en) * 2004-07-16 2006-02-23 Takeda San Diego, Inc. Dipeptidyl peptidase inhibitors
EP1828186A1 (en) * 2004-12-13 2007-09-05 Sunesis Pharmaceuticals, Inc. Pyrido pyrimidinones, dihydro pyrimido pyrimidinones and pteridinones useful as raf kinase inhibitors
US7973022B2 (en) * 2006-02-17 2011-07-05 Idexx Laboratories, Inc. Fluoroquinolone carboxylic acid salt compositions
WO2008061866A1 (en) * 2006-11-20 2008-05-29 Bayer Cropscience Sa New benzamide derivatives
NZ596123A (en) * 2009-05-19 2014-08-29 Dow Agrosciences Llc Compounds and methods for controlling fungi
EP2440204B1 (en) 2009-06-12 2013-12-18 Bristol-Myers Squibb Company Nicotinamide compounds useful as kinase modulators
WO2011031745A1 (en) 2009-09-09 2011-03-17 Achaogen, Inc. Antibacterial fluoroquinolone analogs
WO2013076590A1 (en) * 2011-11-23 2013-05-30 Oxygen Healthcare Research Pvt. Ltd Benzothiazine compounds as h3 receptor ligands
CN108430978B (zh) * 2015-09-25 2022-11-22 路德维格癌症研究所有限责任公司 3-羟基-喹唑啉-2,4-二酮衍生物及其作为核酸酶调节剂的用途
TW202208355A (zh) 2020-05-04 2022-03-01 美商安進公司 作為骨髓細胞觸發受體2促效劑之雜環化合物及使用方法
BR112022022338A2 (pt) 2020-05-04 2023-01-10 Amgen Inc Compostos heterocíclicos como receptor desencadeador expresso em agonistas de células mieloides 2 e métodos de uso

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE1068263B (es) 1959-11-05
US5155110A (en) * 1987-10-27 1992-10-13 Warner-Lambert Company Fenamic acid hydroxamate derivatives having cyclooxygenase and 5-lipoxygenase inhibition
US5283248A (en) 1989-11-21 1994-02-01 Hoffmann-La Roche Inc. Amino substituted pyrimido[1,6-2]benzimidazoles
JP3002507B2 (ja) 1990-08-03 2000-01-24 大日本製薬株式会社 四環式化合物

Also Published As

Publication number Publication date
US6331538B1 (en) 2001-12-18
AU9503998A (en) 1999-05-17
SI1028950T1 (en) 2003-08-31
WO1999021840A1 (en) 1999-05-06
DE69814135T2 (de) 2004-04-01
EP1028950A1 (en) 2000-08-23
US6825199B2 (en) 2004-11-30
DK1028950T3 (da) 2003-09-01
US20020115674A1 (en) 2002-08-22
ATE239000T1 (de) 2003-05-15
DE69814135D1 (de) 2003-06-05
EP1028950B1 (en) 2003-05-02
PT1028950E (pt) 2003-09-30
ZA989783B (en) 1999-04-28

Similar Documents

Publication Publication Date Title
ES2195397T3 (es) Quinazolin-2,4-dionas sustituidas en posicion 7 utiles como agentes antibacterianos.
DK1109812T3 (da) Pyrrolobenzodiazepiner
SV1997000079A (es) Dihidrato d de olancepina ref. x- 11062t
SE9802729D0 (sv) Novel Compounds
ATE293609T1 (de) Antibakteriell wirksam oxazolidinone mit einer thiocarbonylfunktionalität
PT960107E (pt) Compostos de paclitaxel 6-tio-substituidos
EP1126838A4 (en) NITROSIS AND NITROSYAL NON-STEROID ANTI-INFLAMMATORY COMPOUNDS, COMPOSITIONS AND METHODS OF USE
TR200000197T2 (tr) Yeni bileşimler
MX9102407A (es) 4 arilpiperazinas y 4-arilpiperidinas novedosas.
TR200001012T2 (tr) Yeni ariloksi-alkil-dialkilaminler.
DE69319976D1 (de) 7-Substituierte-9-substituierte Glycylamido-6-Demethyl-6-Deoxytetracycline
PT920421E (pt) Derivados de isoxazolina uteis como agentes antimicrobianos
ATE233274T1 (de) Oxyiminopregnancarbolactone
IT1285770B1 (it) Composti corticoidei
TR200000152T2 (tr) Yeni bileşikler.
AR016981A2 (es) Polipeptidos sinteticos
SE9801494D0 (sv) Novel use
TR200000637T2 (tr) Benzoksazin ve benzotiazin türevleri ve bunların ilaçlarda kullanımı.
DK1073447T3 (da) N1-modificerede glycopeptider
ES2154692T3 (es) Dihidrofarnesal.
ES2056876T3 (es) Compuestos piperidinilicos 1,4-disustituidos.
DK1011329T3 (da) 7-Methylthiooxomethyl- og 7-methylthiodioxomethyl-paclitaxeler
ECSP961738A (es) Tetralinas